Jim Simons acquired 57.8k Relmada Therapeutics shares worth $241k. That's 0.00% of their equity portfolio (2625th largest holding). The first Relmada Therapeutics trade was made in Q3 2021. Since then Jim Simons bought shares eight more times and sold shares on nine occasions. The investor's estimated purchase price is $276k, resulting in a loss of 13%.